Anderson Regional Cancer Center is the First Center in the United States to Treat Cancer Patients Using RayStation and the TomoTherapy® Treatment Delivery System
Anderson Regional Cancer Center in Meridian, Mississippi, U.S., has treated its first patient using the combination of RaySearch's treatment planning system (TPS) RayStation, and Accuray Incorporated's TomoTherapy® Treatment Delivery System. This is the first-ever treatment in the U.S. using the two innovative technologies
STOCKHOLM, March 7, 2019 /PRNewswire/ --Anderson Regional Cancer Center first began using RayStation in 2013 with its conventional linear accelerators which provided significant benefits for workflow and patient treatments. The center then added the TomoTherapy System, a highly advanced radiation treatment. Anderson has worked closely with RaySearch and Accuray to join the technologies and is now using RayStation for all radiation treatment planning, which is providing substantial gains in efficiency. Additionally, the high-precision treatment delivery provided by the TomoTherapy System will help ensure the best possible radiation treatments for patients.
The first treatment combining RayStation and TomoTherapy System at Anderson Regional Cancer Center was successfully administered to treat a prostate cancer patient. Moving forward, the center plans to use this combination of TPS and radiation treatment delivery system to also treat cancers of the breast, lung, and head and neck.
Dr. Scott Anderson, Radiation Oncologist and Medical Director at Anderson Regional Cancer Center, said: "We have watched these progressive companies develop through the years, and we are all very excited to be at this juncture. Integrating RayStation planning for multiple accelerator platforms enables us to fully embrace the TomoTherapy System's advantages. The future of our patients certainly looks brighter with the ability to unify these developments."
Paul King, Chief Medical Physicist at Anderson Regional Cancer Center, said: "This clinical launch is very significant. It is a big step in an evolving story that has just begun, considering the quality of RayStation's design as it is today, as well as the intensity and direction of its ongoing development."
John Anderson, President and CEO of Anderson Regional Health System, said: "The Anderson Regional Cancer Center team is continually researching new technologies and advanced medical procedures that will benefit our patients. It took many years and a high level of expertise to bring this collaboration to fruition. We are grateful to Dr. Anderson, Dr. Caleb Dulaney, Paul King, and the entire radiation oncology team for their dedication to increasing quality of life for patients."
Joshua H. Levine, President and Chief Executive Officer of Accuray, said: "We congratulate the Anderson Cancer Center clinical team on its achievement and look forward to continuing to support them as they pave the way in technological innovation focused on improving the lives of their patients. Since its inception, our partnership with RaySearch has been driven by the goal of providing additional flexibility and choice for our customers and enhancing the ease with which our radiation delivery systems fit into a radiation oncology's departmental workflow. With the TomoTherapy® System, the Anderson team has access to a highly precise system that will enable them to treat almost any patient who may benefit from radiation therapy."
Johan Löf, CEO of RaySearch, said: "I'm delighted to hear that the first combined treatment using RayStation and the TomoTherapy System at Anderson Regional Cancer Center was successfully completed. Anderson Regional Cancer Center has always put trust in RaySearch's products, and I'm happy to see that they are in the forefront of this development. RayStation's capability to support multiple linacs, being a machine-independent treatment planning system, helps our customers to get the most out of their treatment delivery systems. Accuray and RaySearch are committed to improving the way radiation therapy is delivered, and I believe that our collaboration strengthens cancer care."
About Anderson Regional Cancer Center
Anderson Regional Cancer Center is a state-of-the-art, comprehensive cancer center offering innovative treatments for various types of cancer. The Center sees approximately 90 outpatients a day for advanced radiation and chemotherapy treatments. With a patient-centered culture and commitment to excellence, Anderson Regional Cancer Center brings current treatment technology to local communities across East Mississippi and West Alabama. The Center is accredited by the American College of Surgeons Commission on Cancer.
About Accuray
Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter and YouTube.
About RaySearch
RaySearch is a medical technology company that develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare*, the next-generation oncology information system, worldwide. Over 2,600 clinics in more than 65 countries use RaySearch's software to improve life and outcomes for patients. The company was founded in 2000 and the share has been listed on Nasdaq Stockholm since 2003.
About RayCare
RayCare is designed to support the complex logistical challenges of modern oncology clinics. It represents the future of oncology information system technology, supporting the vision of one oncology workflow. Many cancer patients receive a combination of treatment types, and RayCare is designed to reflect that. It will efficiently coordinate activities in radiation therapy, chemotherapy and surgery and will offer advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. RayCare is being developed with tomorrow's requirements for advanced analytics and decision support in mind.
About RayStation
RayStation is a flexible, innovative treatment planning system, chosen by many of the leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for IMRT and VMAT optimization with highly accurate dose engines for photon, electron, proton and carbon ion therapy. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare, the next-generation oncology information system. By harmonizing the treatment planning, we enable better care for cancer patients worldwide.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
[email protected]
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59
[email protected]
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
[email protected]
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
SOURCE RaySearch Laboratories
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article